Is there underinvestment in R&D about prevention?

被引：14

作者：

Dranove, D ^{[1
]}

机构：

[1] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA

来源：

JOURNAL OF HEALTH ECONOMICS | 1998年 / 17卷 / 01期

关键词：

D O I：

10.1016/S0167-6296(97)00015-5

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

[No abstract available]

引用

页码：117 / 127

页数：11

共 9 条

[1] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY [J].

DIMASI, JA ;

HANSEN, RW ;

GRABOWSKI, HG ;

LASAGNA, L .

JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) :107-142

[2]

Hartunian N. S., 1981, INCIDENCE EC COSTS M

[3] EVALUATION OF CONSUMER PROTECTION LEGISLATION - 1962 DRUG AMENDMENTS [J].

PELTZMAN, S .

JOURNAL OF POLITICAL ECONOMY, 1973, 81 (05) :1049-1091

[4] VITAMIN-E CONSUMPTION AND THE RISK OF CORONARY HEART-DISEASE IN MEN [J].

RIMM, EB ;

STAMPFER, MJ ;

ASCHERIO, A ;

GIOVANNUCCI, E ;

COLDITZ, GA ;

WILLETT, WC .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (20) :1450-1456

[5] VITAMIN-E CONSUMPTION AND THE RISK OF CORONARY-DISEASE IN WOMEN [J].

STAMPFER, MJ ;

HENNEKENS, CH ;

MANSON, JE ;

COLDITZ, GA ;

ROSNER, B ;

WILLETT, WC .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (20) :1444-1449

[6]

Thomas Lewis, 1975, LIVES CELL

[7]

VISCUSI WK, 1993, J ECON LIT, V31, P1912

[8] THE VERTICAL CHAIN OF RESEARCH-AND-DEVELOPMENT IN THE PHARMACEUTICAL-INDUSTRY [J].

WARD, MR ;

DRANOVE, D .

ECONOMIC INQUIRY, 1995, 33 (01) :70-87

[9]

WEISBROD BA, 1991, J ECON LIT, V29, P523

← 1 →